News Focus
News Focus
Post# of 257302
Next 10
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

Re: Biopharm investor post# 52633

Friday, 09/21/2007 1:20:40 PM

Friday, September 21, 2007 1:20:40 PM

Post# of 257302
>The only question is what the generic firms will get in return for paying these fees.<

What kind of agreed turnaround time for ANDA’s is being considered?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today